Researcher.Life Logo

Human Molecular Genetics : Impact Factor & More

eISSN: 1460-2083pISSN: 0964-6906

Aims and Scope of Human Molecular Genetics

Human Molecular Genetics, first published in 1992, is a semimonthly peer reviewed, scientific journal, published by The Oxford University Press. The journal's focus is research papers on all topics related to human molecular genetics. In addition, two "special review" issues are published each year. There are four professors who share the title of Executive Editor for this journal: Professor Kay Davies from the University of Oxford, Professor Anthony Wynshaw-Boris from Case Western Reserve University, Timothy M. Frayling from the University of Exeter, and Eleftheria Zeggini from Helmholtz Zentrum München. Less

Key Metrics

CiteScore
10.3
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
Scite Index
0.92 5-Year SI
SJR
Q1Genetics
SNIP
1.38
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Human Molecular Genetics

Human Molecular Genetics Journal Specifications

Overview
Publisher OXFORD UNIV PRESS
Language English
Frequency Fortnightly
General Details
LanguageEnglish
FrequencyFortnightly
Publication Start Year1992
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Human Molecular Genetics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Human Molecular Genetics

Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss
  • 17 Jun 2026
  • Human Molecular Genetics
Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.
  • 12 Jun 2026
  • Human molecular genetics
Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.
  • 12 Jun 2026
  • Human molecular genetics
Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.
  • 12 Jun 2026
  • Human molecular genetics
Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.
  • 12 Jun 2026
  • Human molecular genetics
Disease-specific biomarkers of pathogenic HRAS variants in human immortalized keratinocytes.
  • 9 Jun 2026
  • Human molecular genetics
Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss
  • 17 Jun 2026
  • Human Molecular Genetics
Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.
  • 12 Jun 2026
  • Human molecular genetics
Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.
  • 12 Jun 2026
  • Human molecular genetics
Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.
  • 12 Jun 2026
  • Human molecular genetics
Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.
  • 12 Jun 2026
  • Human molecular genetics
Disease-specific biomarkers of pathogenic HRAS variants in human immortalized keratinocytes.
  • 9 Jun 2026
  • Human molecular genetics

FAQs on Human Molecular Genetics